3-deazapurines

Details 3-deazapurines 3-deazapurines

1995-08-14

1996-12-24

Wilson, James O.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536 221, 536 2713, 536 273, 536 276, 536 277, C07H 2102, C07H 2104

Patent

active

055874703

ABSTRACT:
This invention relates to compounds based on the 3-deazapurines ring system and to methods for making such compounds. The invention also generally relates to the field of "antisense" agents, agents that are capable of specific hybridization with a nucleotide sequence of an RNA. The 3- deazapurine-containing compounds of this invention can be useful for modulating the activity of RNA when incorporated into oligonucleotides. Oligonucleotides and their analogs are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins and cleaving RNA in site specific fashions.

REFERENCES:
patent: 3919193 (1975-11-01), Mian et al.
patent: 4318344 (1983-04-01), Rideout et al.
patent: 4481195 (1984-11-01), Rideout et al.
Atherton et al., "The Peptides", Gross and Meienhofer, Eds., Academic Press, NY, 1983, vol. 9, pp. 1-38.
Beaucage et al., "Deoxynucleoside Phosphoramidites-A New Class of Key Intermediates for Deoxypolynucleotide Synthesis", Tetrahedron Letters 1981, 22, 1859-1862.
Beaucage, "3H-1, w-Benzodithiol-3-one 1,1-Dioxide as an Improved Sulfurizing Reagent in the solid-Phase Synthesis of Oligodeoxyribonucleoside Phosphorothioates", J. Am. Chem. Soc. 1990, 112, 1253-1255.
Burman et al., "IV: Studies on Biological Activities and Mechanism of Action 3-deazaguaine Nucleosides", Chem. Scripta 1986, 26, 155-159.
Caruthers, "Synthesis of Oligonucleotides and Oligonucleotide Analogues, Oligodeoxynucleotides", Cohen, ed., CRC Press, Inc., Boca Raton, FL 1989.
"The Chemistry of Heterocyclic Compounds", Weissberger, A., ed., Imidazole and Derivatives, Part 1, Interscience, NY, 1953.
Cook et al., "Synthesis of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic Acid by a Novel Ring Closure of Imidazole Precursors", J. Am. Chem. Soc. 1975, 97, 2916.
Cook et al., "Synthesis and Antiviral and Enzymatic Studies of Certain 3-Deazaguaines and Their Imidazolecarboxamide Precursors", J. Med. Chem. 1978, 21, 1212.
Cook et al., "Synthesis of 7- and 9-.beta.-D-Ribofuranosides of 3-Deaza-6-thioguanine and 3-Deaza-2, 6-diaminopurine by a Novel Ring Closure of 4(5)-Cyano-5(4)-cyanomethylimidazole .beta.-D-Ribofuranosides", J. Org. Chem. 1978, 43, 289.
Greene and Wuts, "Protective Groups in Organic Synthesis", 2nd Edition, John Wiley & Sons, New York, 1991.
Hartman et al, "Synthesis of [2.sup.-14 C] Dezaguaine Mesylate (6-Amino-1,5-Dihydro-4h-[Midazo[4,5.sub.-6 ] Pyridin-4-One-y-.sup.-14 C Methanesultonate), A New Antitumor Agent", J. Labelled Compd. Radiopharm. 1985, 23, 35.
Loose-Mitchell, "Antisense Nucleic Acids as a Potential Class of Pharmaceutical Agents", TIPS 1988, 9, 45-47.
Marcus-Sekura, "Techinques for Using Antisense Oligodeoxyribonucleotides to Study Gene Expression", Anal. Biochemistry 1988, 172, 289-295.
Miles et al., "A Conformational Basis for the Selective Action of Ara-Adenine", J. Theor. Biol. 1977, 67, 499.
Miller et al., "A New Approach to Chemotherapy Based on Molecular Biology and Nucleic Acid Chemistry: Matagen (Masking Tape for Gene Expression", Anti-Cancer Drug Design 1987, 2, 117-128.
Motawai, M. S. et al, "A New route to 2',3'-Dideoxycytidine", Liebigs Ann. Chem. 1990, 599-602.
Pretsch et al., "Spectral Data for Structure Determination of Organic Compounds", 2nd edition, 1989, P. H-15.
Revankar et al, "Synthesis and Antiviral/Antitumor Activities of Certain 3-Deazaguaine Nucleosides and Nucleotides", J. Med. Chem. 1984, 27, 1389.
Rosenmeyer et al., "Syn-Anti Conformational Analysis of Regular and Modified Nucleosides by ID .sup.1 H NOE Difference Spectroscopy: A Simple graphical Method Based on Conformationally Rigid Molecules", J. Org. Chem. 1990, 55, 5784.
Saenger, "Principles of Nucleic Acid Structure", Cantor, C. R., ed., Springer-Verlag, New York, 1983.
Saran et al., "Molecular Orbital Studies on the Structure of Nucleoside Analogs. IV. Conformation of 3-Deazapurine Nucleosides", Int. J. Quantum Chem. 1984, 25, 743.
Stein et al., "Oligodeoxynucleotides as Inhibitors of Gene expression: A Review", Cancer Research 1988, 48, 2659-2668.
Stein et al., "Physicohemical Properties of Phosphorothioate Oligodeoxynucleotieds", Nucleic Acids Res. 1988, 16, 3209-3221.
Van der Krol et al., "Modulation of Eukaryotic Gene Expression by Complementary RNA or DNA Sequences", bioTechniques 1988, 6, 958-973.
Veber and Hirschmann et al., "Isonicotinyloxycarbonyl, a Novel Amino Protecting Group for Peptide Synthesis", J. Org. Chem. 1977, 42, 3286.
Walder, "Antisense DNA and RNA: Progress and Prospects", Genes & Development 1988, 2, 502-504.
Walder et al., "Role of RNase H in Hybrid-Arrested Translation by Antisense Oligonucleotides", PNAS USA 1988, 85, 5011-5015.
Zon, "Synthesis of Backbone-Modified DNA Analogues for Biological Applications", J. Protein Chemistry 1987, 6, 131-145.
Zon, "Oligonucleotide Analogues as Potential Chemotherapeutic Agents", Pharmaceutical Res. 1988, 5, 539-549.
Offensperger, W. et al., "In vivo Inhibition of Duck Hepatitis B Virus Replication and Gene Expression by Phosphorothioate Modified Antisense Oligodeoxynucleotides", The EMBO Journal, 1993, 12(3), 1257-1262.
Simons, M. et al., "Antisense c-myb Oligonucleotides Inhibit Intimal Arterial Smooth Muscle Cell Accumulation in vivo", Nature 1992, 359, 67-70.
Burch, R. and Mahan, "Oligonucleotides Antisense to the Interleukin 1 Receptor mRNA Block the Effects of Interleukin 1 in Cultured Murine and Human Fibroblasts and in Mice", The J. of Clinical Investigation, Inc. 1991, 88, 1190-1196.
Kitajima, I. et al., "Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-.kappa.B", Science 1992, 258, 1792-1795.
Higgins, K. et al., "Antisense Inhibition of the p65 Subunit of NF-.kappa.B Blocks Tumorigenictiy and Causes Tumor Regression", PNAS USA 1993, 90, 9901-9905.
Vlassov, V., "Inhibition of Tick-Borne Viral Encephalitis Expression Using Covalently Linked Oligonucleotide Analogs", in Oligodeoxynucleotides as Antisense Inhibitors of Gene Expresison: Therapeutic Implications, Jun. 18-21, 1989, Rockville, MD.
Sambrook, J. et al., eds., "Molecular Cloning A Laboratory Manual", Cold Spring Harbor Laboratory Press, 1989.
"Antisense Antiviral Drug in Clinical Trials", Antiviral Agents Bulletin Jun. 1992, 5(6), 161-163.
BioWorld Today Dec. 20, 1993, 3.

Affiliated with

Also associated with

Rating

3-deazapurines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-deazapurines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-deazapurines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1179419